Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
-
New drug combo shows promise for rare thymic cancer
Disease control OngoingThis study tested a combination of two drugs, pembrolizumab and sunitinib, in 9 people with advanced thymic cancer that had spread or could not be removed and had stopped responding to standard chemotherapy. The goal was to see if the combination could shrink tumors or stop them …
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New combo attack on stubborn cancers shows promise in early trial
Disease control OngoingThis phase II trial tests whether combining the immunotherapy drug nivolumab with the chemotherapy drug temozolomide can shrink tumors in people with small-cell lung cancer that has returned or not responded to treatment, or advanced neuroendocrine tumors. About 55 participants w…
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC